Observational Study
Copyright ©The Author(s) 2025.
World J Cardiol. Mar 26, 2025; 17(3): 102999
Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.102999
Table 1 Basic clinical data of the patients with cancer in the present study
Characteristics
n
%
Male7357.5
Female5442.5
Age < 65 years4837.8
Age ≥ 65 years7962.2
Head and neck tumor3729.1
Thoracic tumor6248.8
Digestive system tumor1612.6
Others tumor129.5
Stage I1511.8
Stage II2721.3
Stage III5240.9
Stage Ⅳ3326.0
Table 2 Results of the heart rate variability for cancer patients
Index
Reference group[7,8]
Cancer group
P value
Total127
Time domain analysis, 24 hours
SDNN, ms141 ± 39102.12 ± 23.48< 0.05
SDANN, ms127 ± 3595.3 ± 31.25< 0.05
SDNNIDX, ms50 ± 1338.3 ± 21.4< 0.05
Triangle index37 ± 1524.0 ± 5.12< 0.05
pNN50, %7.95 ± 8.154.06 ± 0.59< 0.05
Frequency domain analysis, 24 hours< 0.05
VLF, ms21124 ± 316631.9 ± 275.3< 0.05
LF, ms21170 ± 416426 ± 153< 0.05
LF/HF1.75 ± 0.671.29 ± 0.48< 0.05
Table 3 Association of clinical factors with heart rate variability
Factor
SDNN, ms
pNN50, %
VLF, ms2
LF/HF
SexP > 0.05P > 0.05P > 0.05P > 0.05
    Male104.67 ± 32.574.22 ± 0.75657.6 ± 271.31.35 ± 0.49
    Female101.67 ± 35.354.12 ± 0.71612.5 ± 281.31.23 ± 0.51
Age, yearsP < 0.05P < 0.05P < 0.05P < 0.05
    < 65111.43 ± 32.514.58 ± 0.73665.6 ± 289.11.39 ± 0.43
    ≥ 6592.12 ± 31.313.38 ± 0.56553.6 ± 252.11.12 ± 0.46
Tumor locationP > 0.05P > 0.05P > 0.05P > 0.05
    Cardia104.28 ± 33.674.18 ± 0.65633.8 ± 275.31.31 ± 0.42
    Body103.12 ± 33.74.15 ± 0.76635.3 ± 276.21.35 ± 0.49
    Antrum102.34 ± 35.14.06 ± 0.62611.6 ± 289.21.18 ± 0.51
    Diffuse103.36 ± 35.184.16 ± 0.78631.8 ± 279.41.32 ± 0.48
Clinical typeP < 0.05P < 0.05P < 0.05P < 0.05
    I111.96 ± 32.984.87 ± 0.32698.3 ± 254.61.49 ± 0.52
    II99.86 ± 31.984.07 ± 0.62658.3 ± 224.31.41 ± 0.35
    III87.95 ± 31.583.57 ± 1.22572.1 ± 289.61.38 ± 0.39
    Ⅳ80.15 ± 29.683.27 ± 0.85522.1 ± 259.41.15 ± 0.48